Driving restrictions and incapacitation vulnerability evaluation after ST-segment-elevation myocardial infarction: DRIVE-STEMI study

No abstract available.

View Source

Information

Citation

Singer Z, Wijeysundera HC, Qiu F, Fang J, Manoragavan R, Simpson CS, Ybarra LF. Circulation. 2025; 151(3):282-284.

View Source

Contributing ICES Scientists

Discover More

Journal Article

24/09/2025

The impact of semaglutide on peri-operative cardiovascular outcomes in diabetes

Castrillon F, Carter B, McClure A, Welk B, Clemens KK. Diabetes Obes Metab. 2025 Sep 24 [Epub ahead of print].

Journal Article

24/09/2025

Trends in health care services use and mortality in adults with cardiometabolic diseases during the first year of the pandemic in Ontario, Canada

Kendzerska T, Saymeh M, Pugliese M, Povitz M, Robinson B, Edwards JD, To T, Gershon A. Circ Cardiovasc Qual Outcomes. 2025; e011996. Epub 2025 Sep 24.

Journal Article

12/09/2025

Development of an electronic medical record-based score for heart failure prediction in cancer survivors

Soh CH, Nguyen L, Chu A, Salim A, Abdel-Qadir H, Marwick TH. JACC Adv. 2025; 4(10 Pt 2):102129. Epub 2025 Sep 12.

See All

Driving restrictions and incapacitation vulnerability evaluation after ST-segment-elevation myocardial infarction: DRIVE-STEMI study

Information

Citation

Contributing ICES Scientists

Research Programs

Associated Topics

Associated Sites

Discover More

The impact of semaglutide on peri-operative cardiovascular outcomes in diabetes

Trends in health care services use and mortality in adults with cardiometabolic diseases during the first year of the pandemic in Ontario, Canada

Development of an electronic medical record-based score for heart failure prediction in cancer survivors